Uneingeschränkter Zugang

DNA and BSA-Binding Studies of Dinuclear Palladium(II) Complexes with 1,5-Naphtiridine Bridging Ligands

, ,  und   
22. Juni 2021

Zitieren
COVER HERUNTERLADEN

INTRODUCTION

Palladium(II) complexes are interesting due to their similarity with the corresponding platinum(II) complexes, so they can be used as model molecules for investigation of the antitumor action mechanism of cisplatin and other platinum chemotherapeutics. Reactivity of palladium(II) complexes is 104–105 times higher in relation to analogous with platinum(II) (1, 2, 3, 4).

Although the first results did not show significant antitumor activity of the palladium(II) complexes, they were nevertheless studied more widely. It is considered that the lower activity of these complexes is a consequence of very fast ligands exchange and the inability of the complex to reach the biological target without changes in structure, which increases the risk of adverse effects on biochemical processes in the cell. Since the main reason for the poor biological activity of these palladium complexes lies in its thermodynamic and kinetic lability, it was necessary to make a good selection of ligands, and thus the leaving groups, in the synthesis. In order to overcome such problems, a large number of palladium(II) complexes containing chelating ligands, have been synthesized in order to reduce the reactivity of palladium(II) ion, and increase the stability of the obtained compounds (5). The reactivity and lipophilicity, as well as the antitumor activity of the complex itself, depend on the choice of appropriate ligands. With increasing of compound lipophilicity, its cytotoxicity also increases (6,7). The leaving group must not be extremely labile because it is necessary for the complex to sustain its structural integrity in vivo long enough. For example, 1,10-phenanthroline mononuclear and dinuclear palladium(II) complexes show very good antitumor activity (8). It is assumed that one of the main reasons for good cytotoxicity, in addition to lipophilicity, is the presence of the N-H group, more precisely the hydrogen atom that is suitable for the formation of the hydrogen bonds. This allows more efficient coordination of nucleic acids, containing the electron donor nitrogen atoms, for the palladium(II) ion. So far, only in medicine, the radioactive isotope 103Pd has been used for treatment of fast-growing prostate cancer (9,10).

Numerous palladium complexes with ligands such as putrescine, spermine, edta-type ligands and coumarin derivatives have been synthesized and showed cytotoxic activity approximately equal or even better than cisplatin (11,12). Studies based on the biological activity of mononuclear palladium(II) complexes with ethylenediamine ligand have shown enhanced cytotoxic activity against human leukemia cell lines, relative to cisplatin and other platinum(II) complexes (13). Ethylenediamine dinuclear palladium(II) complexes with pyridine derivatives and phenanthroline as ligands have also shown cytotoxic activity, as well as the ability to reduce the viability of cervical tumor cells (14). The synthesis of palladium(II) complexes with voluminous N-donor ligands leads to the formation of trans-complexes, due to the steric effect. Trans-isomers of palladium(II) complexes have shown better cytotoxicity compared to corresponding cis-isomers (15).

Deoxyribonucleic acid (DNA), important biopolymer in the human body, forms different conformations under physiological conditions, because of interactions that occur within the molecule itself (16, 17, 18). DNA has a role to store and transmit encoded genetic data, which includes transcription, replication, and translation into proteins. Investigating the mechanism of action of cisplatin as a highly represented cytostatic in the treatment of different cancers, it was found that reversible and irreversible binding to the DNA molecule occur. Reversible bonding refers to the formation of covalent bonds between platinum(II) ions and nitrogen atoms from purine and pyrimidine bases, namely N7-nitrogen atoms from guanine, N7 and N1-atoms from adenine and N3-atom from cytosine and thymine (19, 20). NMR spectroscopy and X-ray analysis have shown that interlinked bonds between DNA molecules and metal ions can be formed in different ways. Analogous to platinum(II), studies of palladium(II) complexes interactions with DNA have been performed (21,22).

Serum albumins are a class of blood proteins whose primary function is the transport of molecules and regulation of osmotic pressure in the blood plasma. They play an important role in the transport of metal ions and their complexes to cells and tissues. The concentration of serum albumin in the blood is about 7.0 · 10−4 M (23,24). Human serum albumin (HSA) and bovine serum albumin (BSA) belong to the group of the most studied proteins (23,25). Bovine serum albumin possesses amino acid sequence that has 76% similarity to the human serum albumin (23,26). Investigations of the interactions of serum albumin proteins and transition metal ion complexes used as drugs, is of great importance, because it can lead to a decrease or increase in the biological activity of the drug, as well as to the occurrence of new modes of complex transport. Rapid degradation of many drugs in the body, reduces their therapeutic power. HSA and BSA, as drug transporters, can be used to increase the half-lives of peptides and small molecules that are rapidly subject to degradation. In this way, serum albumins regulate the bioavailability of drugs and bioactive molecules. Due to the extraordinary binding capacity of different ligands, they are also used as model systems for studying interactions with bioactive molecules (27,28).

In this paper, we report synthesis and spectroscopic characterization of two dinuclear palladium(II) complexes with 1,5-naphthyridine bridging ligand, [{Pd(en)Cl}2(μ-1,5-nphe)](NO3)2 (Pd1) and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)] (NO3)2 (Pd2). UV-Vis spectrometry and fluorescent measurements are applied for investigation of the reactions of palladium(II) complexes (Pd1 and Pd2) with DNA and bovine serum albumin (BSA), which results can provide mechanism of their antitumor activity and their possibility to interact with important biomolecules as well as mode of these interactions.

EXPERIMENTAL
Materials

Chemicals and reagents ethylenediamine (en), 1,3-propylenediamine (1,3-pd), 1,5-naphthyridine (1,5-nphe), deoxyribonucleic acid isolated from calf thymus (CT-DNA), bovine serum albumin (BSA), ethidium bromide (EtBr), 0.01 M phosphate buffer and K2[PdCl4] were purchased from Sigma-Aldrich Chemical Co. Bidistilled water was used to prepare a solution of these reagents. Other chemicals used in this work were commercial products of analytical purity and were purchased from a domestic manufacturer.

Instrumental methodes

All pH measurements were performed at 25 °C. For this purpose, a pH meter Mettler Toledo Seven Copmact S220-U was used, which was calibrated in relation to Mettler Toledo buffer solutions for pH = 4.0 and pH = 7.0. The measured pH values were not corrected for the deuterium effect.

Elemental microanalysis for C, H, and N parameters were performed in the Microanalytical Department of the Institute of Chemistry, Faculty of Chemistry, University of Belgrade.

D2O as the solvent and TSP (trimethyl-silylpropane-3-sulfonate) as the reference standard were used to record the 1H and 13C NMR spectrum. The spectra were recorded on a Varian Gemini 200 MHz spectrometer. All reactions were performed in 5 mm diameter NMR cuvettes.

Electronic absorption spectra were recorded on a Shimadzu UV-Vis spectrophotometer. Concentrations of dinuclear palladium(II) complexes were 5 · 10−5 mol/dm3. The electron absorption spectra were recorded in the wavelength range 200–500 nm at 25 °C and the experimental results were processed using the computer program Microsoft Office Excel 2003.

Infra-red (IR) spectra were recorded on a Perkin-Elmer Spectrum One FT-IR spectrometer using the KBr technique, in the wavelength range of 450 – 4000 cm−1.

Fluorescence measurements were performed on an RF-1501 PC spectrophotometer (Shimadzu, Japan).

Synthesis of [Pd(en)Cl2] and [Pd(1,3-pd)Cl2] complexes

Mononuclear palladium(II) complexes [Pd(en)Cl2] and [Pd(1,3-pd)Cl2] (en and 1,3-pd, are bidentate coordinated diamine ligands ethylenediamine and 1,3-propylenediamine, respectively) were synthesized according to a modified procedure previously described in the literature (29, 30, 31).

0.1632 g (5.00 · 10−4 mol) of K2[PdCl4] was dissolved in 25 cm3 of water and the resulting brown solution was transferred to a 100 cm3 double-necked flask supplied with reflux condenser and dropper. The pH value of the solution was adjusted to about 2–3 by adding a solution of HCl with a concentration of 0.1 M. Obtained solution was heated on a water bath, with slow instilment of an equimolar amount (5.00 · 10−4 mol) of ethylenediamine or 1,3-propylenediamine. Instilment is performed slowly for one hour with constant heating, stirring and occasional control of pH values (pH 2-3). During the reaction, the color of the solution changes from brown to light yellow. After refluxing for 5 h, the reaction mixture was left at room temperature overnight. The complexes crystallized from aqueous solution at room temperature. The obtained crystals were filtered off, washed with ethanol and air dried. The yield was about 90%.

Synthesis of dinuclear [{Pd(en)Cl}2(μ-1,5-nphe)](NO3)2 and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)](NO3)2 complexes

Dinuclear palladium(II) complexes, [{Pd(en)Cl}2(μ-1,5-nphe)](NO3)2 (Pd1) and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)](NO3)2 (Pd2), were obtained from the corresponding mononuclear complexes according to a modified procedure previously described in the literature (32, 33, 34).

In 5 cm3 of dimethylformamide 0.0572 g (3.37 · 10−4 mol) of AgNO3 was dissolved and a suspension of the mononuclear [Pd(en)Cl2] or [Pd(1,3-pd)Cl2] complex (3.43 · 10−4 mol) in 10 cm3 of dimethylformamide was added. The reaction mixture was leaved overnight with stirring at room temperature and in the dark. Precipitated AgCl was removed by filtration and in the pale yellow solution of palladium(II) complex, [Pd(en)(dmf)Cl]+ or [Pd(1,3-pd)(dmf)Cl]+, solution of 1,5-naphthyridine (1,5-nphe) in dimethylformamide (molar ratio 2 : 1) was edded dropwise. The reaction mixture was stirred at room temperature for about 4 h in the dark. The volume of the solution was reduced by evaporation of dimethylformamide on a rotary vacuum evaporator.

After the addition of about 20 cm3 of dichloromethane, a light yellow precipitate of the complex [{Pd(en)Cl}2(μ-1,5-nphe)](NO3)2 and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)](NO3)2 was obtained. The resulting precipitate of dinuclear palladium(II) complexes was separated by filtration, washed with methanol, then ether and air dried. The yield of dinuclear palladium(II) complexes was 65% for Pd1 and 50% for Pd2.

Anal. Calcd. for Pd1 (C12H22N8Cl2O6Pd2: FW = 658,11): C, 21.90%; H, 3.37%; N, 17.03%. Found: C, 22.11%; H, 3.26%; N, 17.29%. 1H NMR (200 MHz, D2O, δ, ppm): 8.14 (m, 2H, H3, H7), 9.58 (m, 2H, H4, H8), 10.21 (d, 2H, H2, H6). 13C NMR (50 MHz, D2O, δ, ppm): 130 (C3, C7), 143 (C4a, C8a), 147 (C4, C8), 160 (C2, C6). IR (KBr, ν, cm−1): ~3226, 3100 (N-H stretch); 1582, 1509 (C=C/C=N 1,5-naphthyridine group stretch); 1373, 1356, 1336 (νas(NO3)). UV-vis (H2O, λmax, nm): 303 (ɛ = 7.8 · 103 M−1cm−1), 314 (ɛ = 8.0 · 103 M−1cm−1).

Anal. Calcd. for Pd2 (C14H26N8Cl2O6Pd2: FW = 686,15): C, 24.51%; H, 3.82%; N, 16.33%. Found: C, 24.28%; H, 3.55%; N, 16.53%. 1H NMR (200 MHz, D2O, δ, ppm): 8.23 (m, 2H, H3, H7), 9.55 (d, 2H, H4, H8), 10.17 (d, 2H, H2, H6). 13C NMR (50 MHz, D2O, δ, ppm): 131 (C3, C7), 143 (C4a, C8a), 146 (C4, C8), 160 (C2, C6). IR (KBr, ν, cm−1): ~3241, 3135 (N-H stretch); 1659, 1600, 1589, 1510 (C=C/C=N 1,5-naphthyridine group stretch); 1367, 1295 (νas(NO3)). UV-vis (H2O, λmax, nm): 303 (ɛ = 7.5 · 103 M−1cm−1), 313 (ɛ = 7.2 · 103 M−1cm−1).

Interactions of complexes with CT-DNA
UV-Vis spectrophotometric measurements

Interactions of [{Pd(en)Cl}2(μ-1,5-nphe)](NO3)2 and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)](NO3)2 complexes with deoxyribonucleic acid isolated from calf thymus (CT-DNA) were investigated using UV-Vis spectrophotometry. Based on these measurements, the internal binding constant (Kb) of CT-DNA molecules for dinuclear palladium(II) complexes was determined. A 0.01 M phosphate buffer solution (pH = 7.4) was used to prepare the solutions for UV-Vis measurements. All reactions were performed at 37 °C. The concentration of CT-DNA was determined from the ratio of UV absorbance at 260 and 280 nm (A260/A280). An absorption ratio of 1.8 to 1.9 indicates that CT-DNA has been released from the protein portion, and such a solution was stored at 4 °C for no longer than 7 days. The concentration of CT-DNA was determined based on UV absorption at 260 nm and extinction coefficient ɛ = 6600 M−1cm−1 (35,36).

To determine the internal binding constant (Kb) of CT-DNA molecules and dinuclear palladium(II) complexes, UV-Vis spectra of the solution obtained by mixing dinuclear palladium(II) complexes with CT-DNA were recorded. In all solutions, the concentration of palladium(II) complex was constant (4.51 · 10−5 M), while the concentration of CT-DNA was in the interval (0 – 9.02) · 10−5 M ([complex] / [ CT-DNA] = 0.0 – 2.0). The internal binding constants (Kb) were determined according to the equation: [DNK]/(ɛaf) = [DNK]/(ɛbf) + 1/Kb · (ɛbf) (37), where [DNA] is the concentration of CT-DNA, ɛa and ɛb are the extinction coefficients of the free complex and the complex when the CT-DNA molecule is bound to it, respectively. The extinction coefficient ɛf was defined from the calibration curve obtained by determining the absorption of the free complex at different concentrations. The extinction coefficient ɛa was calculated based on Lambert-Beer's law, as the ratio of the absorption of the tested solution (Aobs) and the concentration of the complex in that solution (Aobs-DNA)/[complex]. The obtained results are presented graphically as the dependence of [DNK]/(ɛaf) versus [DNK]. The slope of the obtained line has the value 1/(ɛbf), while the segment on the y axis is 1/Kb · (ɛbf). The internal binding constant (Kb) was determined from the ratio of the slope of the line and the segment on the y axis.

Fluorescent measurements

Interactions of dinuclear palladium(II) complexes, [{Pd(en)Cl}2(μ-1,5-nphe)](NO3)2 and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)](NO3)2, with CT-DNA in the presence of ethidium bromide (3,8-diamino-5-ethyl-6-phenylphenanthridium bromide, EtBr) were examined using emission fluorescence spectroscopy. A solution of palladium(II) complex was added in to the mixture of EtBr and CT-DNA (1.28 · 10−5 M) in a 1: 1 molar ratio, so that obtained solution have concentration ratio of Pd(II) complex and CT-DNA in range from 0.0 to 0.9. All reactions were carried out in 0.01 M phosphate buffer (pH = 7.4). In order to examine the competitive reactions of the interaction of dinuclear palladium(II) complexes and EtBr with CT-DNA, fluorescent spectra of EtBr/CT-DNA were recorded in the absence and presence of dinuclear Pd(II) complexes. The emission spectra were recorded in the wavelength range 550 – 750 nm, with extinction at 527 nm and fluorescent emission at 612 nm. The Stern-Volmer constant (Ksv) was determined based on the equation: I0/I = 1 + Ksv[Q] (38), where I0 and I are the fluorescence intensities before and after the addition of the palladium(II) complex to the EtBr/CT-DNA solution, while [Q] is the concentration of the Pd(II) complex. The obtained results are presented graphically as the dependence of I0/I from [Q]. The Stern-Volmer constant (Ksv) was obtained from the slope of the acquired line. The stability constant (Ka) as well as the number of binding sites (n) was obtained based on the equation: log (I0–I)/I = logKa + n · log[Q] (39, 40, 41). The obtained results are presented graphically as the dependence of log (I0–I)/I from the log[Q]. The value of Ka was obtained from the intersection of the line with the y axis, and the number of connecting points (n) from the slope of the line.

Interactions of Pd(II) complexes with albumin

Emission fluorescence spectroscopy were used to examine interactions of dinuclear palladium(II) complexes [{Pd(en)Cl}2(μ-1,5-nphe)](NO3)2 and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)](NO3)2 with bovine serum albumin (BSA). Emission spectra were recorded in the wavelength range 300–500 nm, with extinction at 295 nm (32). The binding effect of the tested albumin complexes was observed based on the reduction of the albumin emission intensity (1.6 · 10−6 M in 0.01 M PBS) to 352 nm after the addition of palladium(II) complexes (0–4.0) · 10−5 M. All emission spectra were recorded under the same experimental conditions.

The Stern-Volmer constant (Ksv) was determined based on the equation: I0/I = 1 + Ksv[Q] = 1 + kqτ0[Q], where I0 is the initial fluorescence intensity of tryptophan in BSA, and I is the fluorescence intensity of tryptophan in BSA after addition of palladium(II) complex in protein solution, kq is the fluorescence quenching constant, τ0 is the average time for fluorescence of albumin in the absence of the complex and [Q] is the concentration of the complex. The binding constant (Ka) as well as the number of binding sites (n) were obtained on the basis of Scatchard's equation: log(I0–I)/I = logKa + n · log[Q]. The results are presented graphically as the dependence of log(I0–I)/I from log [Q], the value of Ka is aquired from the intersection of the obtained line with the y axis, and the number of connecting points (n) from the slope of the line.

RESULTS AND DISCUSSION

In this work, two dinuclear palladium(II) complexes, [{Pd(en)Cl}2(μ-1,5-nphe)](NO3)2 (Pd1) and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)](NO3)2 (Pd2), containing 1,5-naphthyridine (1,5-nphe) as bridging ligand, while ethylenediamine (en) and 1,3-propylenediamine (1,3-pd) are bidentate coordinated diamine ligands, were synthesized and characterized by elemental microanalysis, NMR (1H and 13C), IR spectroscopy and UV-Vis spectrophotometry. Figure 1 shows the structural formulas of ligands, and the synthesized dinuclear palladium(II) complexes. Interactions of dinuclear palladium(II) complexes with calf thymus deoxyribonucleic acid (CT-DNA) were investigated using UV-Vis spectrophotometry and fluorescence spectroscopy. In addition, fluorescence spectroscopy was used to study the interaction of Pd1 and Pd2 complexes with bovine serum albumin (BSA).

Figure 1.

Structural formulas of 1,5-naphthyridine (1,5-nphe), ethylenediamine (en) and 1,3-propylenediamine (1,3-pd), and dinuclear palladium(II) complexes Pd1 and Pd2.

Synthesis and characterization of dinuclear palladium(II) complexes

Dinuclear palladium(II) complexes, [{Pd(en)Cl}2(μ-1,5-nphe)](NO3)2 (Pd1) and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)](NO3)2 (Pd2), were obtained from the corresponding mononuclear complexes according to a modified procedure previously described in the literature (32, 33, 34).

As shown in Figure 1, the synthesized dinuclear palladium(II) complexes have the same bridging 1,5-naphthyridine ligand and different bidentate coordinated diamine ligands. 1H and 13C NMR spectra of 1,5-naphthyridine, ethylediamine, 1,3-propylenediamine as well as Pd1 and Pd2 complexes were recorded in D2O as solvent. NMR data for ligands and dinuclear palladium(II) complexes is given in Table 1, while 1H and 13C NMR spectra of Pd1 and Pd2 complexes in Figure 2.

1H and 13C NMR chemical shifts (δ, ppm) for 1,5-naphthyridine (1,5-nphe), ethylenediamine (en), 1,3-propylenediamine (1,3-pd) and the corresponding dinuclear palladium(II) complexes

ligand/complex NMR shifts
1H 13C
H2, H6 H4, H8 H3, H7 alifatic protons C2, C6 C4, C8 C3, C7 C4a, C8a L
1,5-nphe 8.57 dd 7.89 d 7.48 dd 154 139 128 144
en 2.64 s (CH2) 45 (CH2)
Pd1 10.21 d 9.58 d 8.14 m 2.76 m (CH2) 160 147 130 143 50 (CH2)
1,3-pd 1.60 m (H2, CH2) 2.47 m (H1,H3,CH2) 29 (C2, CH2) 39 (C1,C3, H2)
Pd2 10.17 d 9.55 d 8.23 m 1.85 m (H2,CH2) 2.76 m (H1,H3,CH2) 160 146 131 143 30 (C2, CH2) 43,44 (C1,C3, CH2)

In the 1H NMR spectrum of free 1,5-naphthyridine, two multiplets (doublet-doublets, dd) occur at 7.48 (H3, H7) and 8.57 (H2, H6) ppm, derive from the equivalent protons of the two condensed pyridine rings. The doublet at 7.89 ppm originates from the H4 and H8 protons of 1,5-nphe.

Figure 2.

1H and 13C NMR spectra of [{Pd(en)Cl}2(μ-1,5-nphe)](NO3)2 (Pd1) and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)](NO3)2 (Pd2) complexes.

After coordination of diamine ligand to the palladium(II) ion, the signal shifts downfield (Fig. 2 and Table 1). The shifts of the signals, which correspond to the 1,5-nphe protons after coordination for the palladium(II) ion, are a consequence of the delocalization of the charge transmitted through the pyridine rings (20,32,42). The multiplet at 2.76 ppm in the 1H NMR spectrum of the Pd1 complex, correspond to methylene protons of bidentate coordinated ethylenediamine. This signal was shifted by Δδ = 0.12 ppm downfield in regard to free ethylenediamine. In the aliphatic part of the 1H NMR spectrum of the Pd2 complex, two multiplets appear at 1.85 and 2.60 ppm due to the CH2 protons at position 2 and the CH2 protons at position 1 and 3 (Fig. 1, Table 1). Signals derived from these protons after coordination were shifted downfield (Δδ = 0.25 ppm for methylene protons at position 2 and Δδ = 0.19 ppm for same protons at positions 1 and 3) in regards to the uncoordinated 1,3-pd.

In the 13C NMR spectra of the Pd1 and Pd2 complexes, in the aromatic region, four signals from the carbon atoms of the 1,5-naphthyridine ligand (C2 and C6, C4 and C8, C4a and C8a, C3 and C7) appears. The position of these signals differs significantly from those of the uncoordinated 1,5-nphe (Table 1). After coordination of 1,5-nphe for Pd(II) the signals for the carbon atoms in the heterocyclic aromatic ring move downfield. The signal at 50 ppm originating from from the carbon atoms of bidentate-coordinated ethylediamine in Pd1, are shifted by Δδ = 5 ppm in regarde to the uncoordinated en ligand. Also, in the spectrum of the Pd2 complex, the signals corresponding to the C atoms of the coordinated 1,3-pd ligand are shifted by Δδ = 1–5 ppm downfield relative to the signals of the uncoordinated ligand.

UV-Vis spectrophotometry

The UV-Vis spectra of the Pd1, Pd2 complexes and free 1,5-nphe ligand are given in Figure 3. The first absorption maximum is located in the wavelength range of 296 to 310 nm, while the second maximum is in the range of 310 to 320 nm. All absorption maxima of the synthesized complexes have a batochromic shift after the coordination of 1,5-naphthyridine, due to π….π electron transitions in the heterocyclic 1,5-nphe ligand.

Figure 3.

UV-Vis spectra of dinuclear [{Pd(en)Cl}2 (μ-1,5-nphe)]2+ and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)]2+ complexes and free 1,5-nphe ligand.

IR spectroscopy

IR spectra of Pd1 and Pd2 complexes, recorded in the wavelength range 4000 - 450 cm-1, show bands corresponding to coordinated 1,5-nphe ligand, as well as bands of bidentate coordinated ethylenediamine (en) and 1,3-propylenediamine (1,3-pd) (Fig. 4).

Figure 4.

IR spectra of Pd1 and Pd2 complexes, KBr, 4000-450 cm−1.

In the IR spectra of dinuclear palladium(II) complexes, two very strong bands in the range of 3280 - 3098 cm−1 were observed, which correspond to asymmetric and symmetric vibrations of the coordinated amino group of ethylenediamine and 1,3-propylenediamine. The medium-strength band in the region of 1500–1650 cm−1 correspond to the C = C and C = N vibrations of the aromatic 1,5-naphthyridine ring. A strong and wide band at ~1364 - 1384 cm−1 indicates the existence of NO3 ions in the outer coordination sphere of dinuclear palladium(II) complexes.

Interactions of dinuclear palladium(II) complexes with DNA
UV-Vis spectrophotometric measurements

UV-Vis spectrophotometry is a simple and efficient method, which is used to determine the mode of coordination or interaction of metal complexes with deoxyribonucleic acid (DNA). Transition metal complexes can interact with DNA covalently or noncovalently (43). Coordination of DNA molecules, most commonly via N7 atoms from guanine to a metal ion, creates a covalent bond, while noncovalent interactions include intercalation, hydrogen bond formation, and electrostatic interactions. After the interaction of the metal complex with the DNA, the intensity of the absorbance may decrease (hypochromic effect) or increase (hyperchromic effect). Also, the absorption maximum may have a batochromic or hypsochromic shift. Based on the obtained results of UV-Vis spectrophotometry, the internal binding constants (stability constants) of DNA to the metal ion, can be calculated. The UV-Vis spectra of [{Pd(en)Cl}2(μ-1,5-nphe)]2+ and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)]2+ complexes in the absence and presence of different concentrations of CT-DNA, ([complex] / [CT-DNA] = (0.0 – 2.00) · 10−4 M) are shown in Figure 5.

Figure 5.

Absorption spectra of [{Pd(en)Cl}2(μ-1,5-nphe)]2+ and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)]2+ complexes in 0.01 M phosphate buffer before and after addition of CT-DNA. [Pd(II) complex] = 4.51 · 10−5 M, [DNA] = (0 – 2.00) · 10−4 M.

After the addition of CT-DNA to the solution of dinuclear palladium(II) complexes, a hyperchromic effect (increase of the absorption maximum) in UV-Vis spectra can be observed, based on which it can be concluded that the complex interacts with CT-DNA. The hyperchromic effect indicates that our complexes with CT-DNA achieve interactions of electrostatic nature or π→π* interactions which occurs as a consequence of the interactions of aromatic rings in complexes with bases in CT-DNA (44).

The internal binding constants (Kb) were calculated from the change in absorption at the appropriate wavelength after the addition of CT-DNA according to the equation given in the Experimental part (2.5.1). The obtained results are presented graphically as the dependence of [DNK]/(ɛaf) from DNA concentration. The slope of the obtained line has the value 1/(ɛbf), while the segment on the y axis is 1/Kb · (ɛb - ɛf). The internal binding constant (Kb) is determined from the ratio of the slope of the line and the segment on the y axis (Fig. 5). The obtained values for the internal binding constants (Kb) are shown in Table 2. Based on Kb, we can conclude that strong interactions occur between investigated Pd(II) complexes and CT-DNA, which are characteristic for intercalators.

Internal binding constants (Kb), changes in Gibbs energy (ΔG) and hypochromism (H) of the investigated dinuclear palladium(II) complexes, Pd1 and Pd2, with CT-DNA

complex Kb · 104 (M−1) ΔG (kJ/mol) H
[{Pd(en)Cl}2 (μ-1,5-nphe)]2+ (7.50 ± 0.05) −28.93 22.42
[{Pd(1,3-pd)Cl}2 (μ-1,5-nphe)]2+ (4.00 ± 0.03) −27.31 25.77

Kb values of the tested complexes are about 10 times lower then the same for the typical intercalator ethidium bromide (EtBr) to DNA, (Kb = 1.23 · 105 M−1) (45), indicating that the interactions of the Pd(II) complexes are weaker compared to EtBr. The higher value of Kb for the Pd1 complex compared to the Pd2, indicates that the Pd1 complex has a higher affinity of interaction with CT-DNA, which can be attributed to the smaller steric effect of the bidentate coordinated five-membered ethylenediamine ring compared to the six-membered 1,3-propylenediamine ring in Pd2. The change in Gibbs energy (ΔG, Table 2) of the Pd(II)/CT-DNA adduct was calculated using the following equation: ΔG = −RTlnKb. Negative values of Gibbs energy indicate spontaneous interaction of dinuclear palladium(II) complexes, Pd1 and Pd2, with CT-DNA.

Fluorescent measurements

Fluorescence emission spectroscopy was used for studying the interactions of dinuclear Pd1 and Pd2 complexes with the CT-DNA molecule and ethidium bromide (EtBr) as a typical intercalator. Changes in EtBr/CT-DNA emission spectra after addition of the complex solution, decrease or increase in fluorescent emission, indicates that the complex replaces EtBr, and a new adduct of CT-DNA/Pd(II) complex is formed (46).

The emission spectra of EtBr/CT-DNA in the presence of Pd1 and Pd2 complexes are shown in Figure 6. Addition of palladium(II) complex (with increasement of complex concentration) leads to a decreasement of the emission intensity at 612 nm, indicating competition reaction between EtBr and the tested Pd(II) complexes in relation to CT-DNA. Extrusion of EtBr from the EtBr/CT-DNA with Pd(II) complex proves that intercalation the Pd(II) complex occured.

Figure 6.

EtBr/CT-DNA emission spectra in the presence of [{Pd(en)Cl}2(μ-1,5-nphe)]2+ and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)]2+ complex. [EtBr] = 1.28 · 10−5 M, [DNA] = 1.28 · 10−5 M, [Pd(II) complex] = (0 – 1.28) · 10−5 M. Inserted graph: Dependence of I0/I from concentration [Q].

The intensity of the interaction of Pd1 and Pd2 complexes with CT-DNA was determined based on the Stern-Volmer constant (Ksv) using the Sten-Volmer equation: I0/I = 1 + Ksv[Q], where I0 and I are the fluorescence intensities before and after the addition of palladium(II) complex in EtBr/CT-DNA solution, while [Q] is the concentration of Pd(II) complex. The obtained results are graphically presented as the dependence of I0/I from [Q]. The Stern-Volmer constant (Ksv) was determined from the slope of the obtained line.

From Ksv values (Table 3), it can be concluded that the investigated dinuclear palladium(II) complexes show high affinity for CT-DNA and can displace EtBr from the EtBr/CT-DNA adduct. The stability constant (Ka) was determined from the experimental results, as well as the number of binding sites (Table 3), showing that the Ka follows the Ksv values. The obtained values for the Stern-Volmer constant (Ksv), the stability constant (Ka) and the number of binding sites (n) confirm that the dinuclear Pd(II) complexes, Pd1 and Pd2, reacts with CT-DNA by intercalating between two nucleotide strands of DNA and displacing EtBr. These results are in agreement with the Kb values obtained by UV-Vis spectrophotometry. The higher number of binding sites for the Pd1 complex, once again indicates the stronger interaction of this complex with CT-DNA compared to the Pd2 complex.

Stern-Volmer constant (Ksv), stability constant (Ka) and number of binding sites (n) of the investigated dinuclear palladium(II) complexes with CT-DNA

complex Ksv · 105 (M1) Ka · 105 (M1) n
[{Pd(en)Cl}2 (μ-1,5-nphe)]2+ (4.50 ± 0.04) (8.80 ± 0.02) 1.7
[{Pd(1,3-pd)Cl}2 (μ-1,5-nphe)]2+ (2.80 ± 0.06) (2.50 ± 0.05) 1.1
Interactions of dinuclear Pd(II) complexes, Pd1 and Pd2, with BSA

Serum albumin, as the most common blood plasma protein, is one of the most studied proteins (23,25). It plays an important role in the transport of metal ions and their complexes through the blood system to cells and tissues. Bovine serum albumin (BSA) is the most studied serum albumin due to its structural similarity to human serum albumin (HSA). Namely, human serum albumin contains one tryptophan at the Trp-214 position, while BSA contains two tryptophan residues, Trp-134 and Trp-214. The bovine serum albumin (BSA) solution shows intense fluorescent emission at λem, max = 352 nm, and after excitation at 295 nm (47). After the addition of the Pd1 or Pd2 complex to the BSA solution, the fluorescence intensity at λ = 352 nm decrease (Fig. 7) based on it can be concluded that the tested complexes interact with this biomolecule. The decrease in fluorescence intensity can be attributed to changes in protein structure, which occur due to changes in the tryptophan environment in BSA, because of protein binding to complexes (48).

Figure 7.

BSA emission spectra in the presence of [{Pd(en)Cl}2(μ-1,5-nphe)]2+ and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)]2+ complexes. [BSA] = 1.60 · 10−6 M, [Pd(II) complex] = (0 – 4.00) · 10−5 M; λex = 295 nm. Inserted graph: Dependence of Io/I from concentration [Q].

The values of the dynamic Stern-Volmer constant (Ksv) and the fluorescence quenching constant (kq) for complex interactions with BSA were determined using the Stern-Volmer equation. The values of the constants Ksv and kq for the interaction of the studied Pd1 and Pd2 complexes with BSA are given in Table 4. In addition, Table 4 shows the values of binding constants (Ka) as well as the number of albumin binding sites (n) for Pd(II) complexes, which were obtained on the basis of Scatchard's equation (Experimental part 2.6). The obtained results are graphically presented as the dependence of log(I0–I)/I from log[Q], the value of Ka is obtained from the intersection of the line with the y axis, and the number of connecting points (n) from the slope of the line.

Stern-Volmer constant (Ksv), quenching constant (kq), binding constant (Ka) and number of binding sites (n) for interactions between BSA and dinuclear Pd1 and Pd2 complexes.

complex Ksv · 105 (M1) kq · 1012 (M1s1) Ka · 109 (M1) n
[{Pd(en)Cl}2 (μ-1,5-nphe)]2+ (2.80 ± 0.03) (28 ± 2) (1.20 ± 0.05) 1.8
[{Pd(1,3-pd)Cl}2 (μ-1,5-nphe)]2+ (3.90 ± 0.04) (39 ± 1) (1.20 ± 0.02) 1.8

Based on the linearity in Stern-Volmer graphs, it can be concluded that both complexes lead to the quenching of tryptophan emission in the BSA molecule. Ksv values for Pd1 and Pd2 complex (Table 4) indicate a very similar binding affinity of BSA for the tested complexes. The values of n for both complexes are 1.8, which indicates that there are approximately two possible sites in the protein suitable for complex binding. The quenching constants (kq) are greater than 1010 and indicate a static emission quenching mechanism (49). Ka value leads to conclusion that the Pd1 and Pd2 complexes can bind to BSA and thus be transported to the cell and hydrolyze the bond with BSA at the appropriate site in the cell.

CONCLUSION

In this paper, two dinuclear complexes, [{Pd(en)Cl}2(μ-1,5-nphe)](NO3)2 (Pd1) and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)](NO3)2 (Pd2), (ethylenediamine (en) and 1,3-propylenediamine (1,3-pd) are bidentate coordinated diamine ligands and 1,5-naphthyridine (5-nphe) bridging ligand) were synthesized. The structure of these complexes was confirmed based on the results of elemental microanalysis, UV-Vis, IR, NMR (1H and 13C) spectroscopy.

Interactions of synthesized dinuclear palladium(II) complexes with deoxyribonucleic acid were investigated using UV-Vis spectrophotometry and fluorescence spectroscopy. UV-Vis spectrophotometric data showed that after the addition of CT-DNA to the solution of dinuclear palladium(II) complexes, a hyperchromic effect occurs, based on which we can conclude that the complex interacts with CT-DNA without changing its structure. Higher value of Kb for complex Pd1 indicates that this complex has greater binding affinity in comparison to Pd2. The emission spectra demonstrate that the investigated Pd1 and Pd2 complexes can displace the ethidium bromide intercalator from the CT-DNA/EtBr adduct. From the high Stern-Volmer constants (Ksv) values it can be concluded that these Pd(II) complexes act as intercalators showing strong interactions with DNA, and higher value of the stability constant (Ka) for Pd1 confirms results from UV-Vis spectrophotometry. Stronger binding of Pd1 complex to the DNA helix can be attributed to the smaller steric effect of the five-membered ethylenediamine ligand in relation to the six-membered 1,3-propylenediamine ring.

Fluorescence spectroscopy were used for investigation of interactions of Pd1 and Pd2 complexes with bovine serum albumin (BSA). The fluorescence intensity of tryptophan decreases proportionally to the increasement in the total concentration of the added complex. From calculated values of the constants (Ksv and Ka) it can be concluded that Pd1 and Pd2 complexes can bind to BSA and then be transported to the cell. Also, the number of binding sites (n) show that two binding sites of BSA are accessible for interaction with these metal complexes.

The results obtained in this paper contribute to a better understanding of the interactions of dinuclear palladium(II) complexes containing 1,5-naphthyridine as a bridging ligand, with biologically important molecules, such as DNA and BSA.

Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
4 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Klinische Medizin, Klinische Medizin, andere